Optimal Platelet Dose Strategy for Management of Thrombocytopenia

NCT00128713 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1351
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Carelon Research

Collaborators